Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Fallopian Tube Neoplasms × Histamine Antagonists × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 1 Neoplasm, Residual 1 Lymphoma, Non-Hodgkin 1 Leukemia, Hairy Cell 1 Carcinoma in Situ 1

Interventions

Paclitaxel 49 Carboplatin 47 Bevacizumab 35 Taxes 22 liposomal doxorubicin 18 Gemcitabine 16 pembrolizumab 14 Immunoglobulin G 14 Disulfides 14 Topotecan 10 Cisplatin 9 rucaparib 8 olaparib 7 Docetaxel 7 Cyclophosphamide 7 mirvetuximab soravtansine 6 cediranib 6 Magnetic Resonance Spectroscopy 6 Doxorubicin 6 pazopanib 5 Specimen Handling 5 Nivolumab 5 sargramostim 4 niraparib 4 Surgical Procedures, Operative 4 Cytoreduction Surgical Procedures 4 Albumin-Bound Paclitaxel 4 fludarabine phosphate 3 belinostat 3 avelumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡